From stem cells to lymphocytes: Biology and transplantation

Immunological Reviews

Volumn 157, Issue , 1997, Pages 13-40

  Aguila, Hector L ^a   Akashi, Koichi ^a   Domen, Jos ^a   Gandy, Kimberly L ^a   Lagasse, Eric ^a   Mebius, Reina E ^c   Morrison, Sean J ^b   Shizuru, Judy ^a   Strober, Samuel ^a   Uchida, Nobuko ^d   Wright, Douglas E ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; CELL DIFFERENTIATION; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; LYMPH NODE; ONTOGENY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS; TRANSPLANTATION;

EID: 8544252451     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00971.x     Document Type: Review

References (282)

1. Till J, McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961;14:1419-1430.
2. Gowans JL, Gesner B, McGregor D. The immunological activity of lymphocytes. In: Wolstenholme G, O'Connor M, eds. Biological activity of the leucocyte. London: Churchill; 1961. p.32.
3. Miller JFAP. Immunological function of the thymus. Lancet 1961;2:748-749.
4. Martinez C, Kersey J, Papermaster B, Bood R. Skin homograft survival in thymectomized mice. Proc Soc Exp Biol Med 1962;109:193-196.
5. Till J, McCulloch E. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc Natl Acad Sci USA 1963;51:29-36.
6. Siminovitch L, McCulloch E, Till J. The distribution of colony-forming cells among spleen colonies. J Cell Comp Physiol 1963;62:327-336.
7. Wu A, Till J, Siminovitch L, McCulloch E. A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J Cell Physiol 1967;69:177-184.
8. Wu A, Till J, Siminovitch L, McCulloch E. Cytological evidence for a relationship between normal hematopoietic colony-forming cells and cells of the lymphoid system. J Exp Med 1968;127:455-467.
9. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335-344.
10. Whitlock CA, Witte ON. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 1982;79:3608-3612.
11. Ezine S, Weissman IL, Rouse RV. Bone marrow cells give rise to distinct cell clones within the thymus. Nature 1984;309:629-631.
12. Visser JW, Bauman JGJ, Mulder AH, Eliason JF, deLeeuw AM. Isolation of murine pluripotent hematopoietic stem cells. J Exp Med 1984;159:1576-1590.
13. lo hematopoietic stem cell. Cell 1986;44:653-662.
14. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
15. Aihara Y, Buhring H-J, Aihara M, Klein J. An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol 1986;16:1391-1399.
16. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986;67:842-845.
17. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwanz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1 a cells. J Immunol 1984;133:157-165.
18. Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart RK, Civin CI. Antigenic analysis of hematopoiesis. V Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 1986;14:878-886.
19. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992;89:2804-2808.
20. Ogawa M, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991;174:63-71.
21. + cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 1992;175:175-184.
22. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994;1:661-673.
23. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci USA 1995;92: 10302-10306.
24. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/G-CSF induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 1997;94:1908-1913.
25. Spangrude GJ, Brooks DM. Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset. Blood 1992;80:1957-1964.
26. Spangrude GJ, Brooks DM. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 1993;82:3327-3332.
27. + bone marrow cells highly enriched for pluripotent stem cells. Exp Hematol 1996;24:936-943.
28. Krause DS, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994;84:691-701.
29. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 1994;84:2554-2565.
30. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
31. Morel F, Galy A, Chen B, Szilvassy S. Characterization of CD34 negative hematopoietic stem-cells in murine bone marrow. Blood 1996;88:2503.
32. - progenitor cells. Blood 1991;77:1218-1227.
33. Prosper F, Stroncek D, Verfaillie CM. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood 1996;88:2033-2042.
34. Civin CI, Almeida-Porada G, Lee MJ, Olweus J, Terstappen LW, Zanjani ED. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 1996;88:4102-4109.
35. Randall TD, Lund FE, Howard MC, Weissman IL. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 1996;87:4057-4067.
36. + cells. Blood 1996;87:949-955.
37. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 1990;347:188-189.
38. + mouse hematopoietic stem cells separated by counterflow centrifugal elutriation. Exp Hematol 1996;24:649-659.
39. Wagner JE, et al. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 1995;86:512-523.
40. Orlic D, Fischer R, Nishikawa S, Nienhuis AW, Bodine DM. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 1993;82:762-770.
41. Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Nad Acad Sci USA 1995;92:4601-4605.
42. Jones RJ, et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995;85:2742-2746.
43. Jones RJ, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 1996;88:487-491.
44. Morrison SJ, Wright DE, Cheshier S, Weissman IL. Hematopoietic stem cells: challenges to expectations. Curr Opin Immunol 1997 (In press).
45. Mulder AH, Visser JW. Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence. Exp Hematol 1987;15:99-104.
46. Bertoncello I, Hodgson GS, Bradley TR. Multiparameter analysis of transplantable hemopoietic stem cells. I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol 1985;13:999-1006.
47. Visser JW, de Vries P. Isolation of spleen-colony forming cells (CFU-s) using wheat germ agglutinin and rhodamine 123 labeling. Blood Cells 1988;14:369-384.
48. Spingrude GJ, Johnson GR. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:7433-7437.
49. + hemopoietic stem cells. J Exp Med 1992;175:1443-1447.
50. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 1995;85:1006-1016.
51. Zijlmans JM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 1995;92:8901-8905.
52. Udomsakdi C, Eaves CJ, Sutherland HJ, Lansdorp PM. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 1991;19:338-342.
53. Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 1996;88:1297-1305.
54. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993;177:1331-1342.
55. Visser JW, et al. Culture of hematopoietic stem cells purified from murine bone marrow. Semin Hematol 1991;28:117-125.
56. Spangrude G, Thomas D. Experimental manipulation of mouse bone marrow stem cells: gene transduction using a novel retroviral vector. Acta Haematol 1996;93:132(Abstract).
57. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94.
58. + cells is directly related to their position within the G0/G1 phase of cell cycle. Blood 1996;88:541(Abstract).
59. Wolf NS, Kone A, Priestley GV, Bartelmez SH. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodimine 123 FACS selection. Exp Hematol 1993;21:614-622.
60. Ellwart JW, Dormer P. Vitality measurement using spectrum shift in Hoechst 33342 stained cells. Cytometry 1990;11:239-243.
61. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
62. +, CD38 hematopoietic stem cell. Blood 1994;83:1515-1526.
63. Traycoff CM, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994;22:215-222.
64. + HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 1991;17:287-295.
65. Sanchez MJ, Holmes A, Miles C, Dzierzak E. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 1996;5:513-525.
66. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their adult bone marrow counterparts. Blood 1996;87:3500-3507.
67. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, Weissman IL. Identification of a lineage of multipotent hematopoietic progenitors. Development 1997;124:1929-1939.
68. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med 1996;2:1011-1016.
69. Bodine D, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996;88:89-97.
70. Uchida N, et al. The unexpected G0/G1 tell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997;89:465-472.
71. Harrison DE, Zhong R. The same exhaustible multilineage precursor produces both myeloid and lymphoid cells as early as 3-4 weeks after marrow transplantation. Proc Natl Acad Sci USA 1992;89: 10134-10138.
72. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
73. Allsopp RC, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89: 10114-10118.
74. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992;27:375-382.
75. Morrison S, Prowse KR, Ho P, Weissman I. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-216.
76. Georgopoulos K, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994;79:143-156.
77. Ikuta K, et al. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 1990;62:863-874.
78. Kantor AB, Stall AM, Adams S, Herzenberg LA, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA 1992;89:3320-3324.
79. Hardy RR, Hayakawa K. Generation of Ly-1 B cells from developmentally distinct precursors: enrichment by stromal cell culture or cell sorting. CD 5 B cells in development and disease. Ann NY Acad Sci 1992;651:99-111.
80. Harrison DE. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med 1983;157:1496-1504.
81. Ogden DA, Micklem HS. The fate of serially transplanted bone marrow cell populations from young and old donors. Transplantation 1976;22:287-293.
82. Harrison DE, Astle CM. Loss of stem cell repopulating ability upon transplantation: effects of donor age, cell number, and transplantation procedure. J Exp Med 1982;156:1767-1779.
83. Farrar JJ, Loughman BE, Nordin AA. Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and middle aged mice. J Immunol 1974;112:1244-1249.
84. Francus T, Chen YW, Staiano-Coico L, Hefton JM. Effect of age on the capacity of the bone marrow and the spleen cells to generate B lymphocytes. J Immunol 1986;137:2411-2417.
85. Dunn TB. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst 1954;14:1281-1433.
86. + cells from patients with chronic myeloid leukemia. Blood 1996;88:1796-1804.
87. + cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or alpha-interferon-intolerant patients with chronic myeloid leukemia. Blood 1996;87:4348-4357.
88. Juttner CA, To LB, Haylock DN, Branford A, Kimber RJ. Circulating autologous stem cells collected in very early remission from acute non-lymphobkstic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985;61:739-745.
89. Juttner C, To L. Autologous peripheral blood stem cell transplantation: potential advantages, practical considerations and initial clinical results. In: Atkinson K, ed. Clinical bone marrow transplantation: a reference text book. Cambridge: Cambridge Universtiy Press; 1994. p. 142.
90. Bodine DM, Seidel NE, Zsebo KM, Orlic D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 1993;82:445-455.
91. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 1993;90:3760-3764.
92. Laterveer L, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-2275.
93. Laterveer L, et al. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-788.
94. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 1996;87:1644-1653.
95. Roberts A, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995;86:1600-1605.
96. Siegert W, Serke S. Cytokine mobilized blood CD34-expressing cells are not cycling. Bone Marrow Transplant 1996;17:467-470.
97. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Devl Biol 1995;11:35-71.
98. Sanchez M-J, Holmes A, Miles C, Dzierzak E. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 1996;5:513-525.
99. Moore MAS, Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970;18:279-296.
100. Weissman I, Papaioannou V, Gardner R. Fetal hematopoietic orgins of the adult hematolymphoid system. In: Clarkson B, Mark P, Till J, eds. Cold Spring Harbor Conferences on Cell Proliferation. Vol 5. Differentiation of normal and neoplastic hematopoietic cells. New York: Cold Spring Harbor Lab; 1978. p.33-47.
101. Wood WG, Clegg JB, Weatherall DJ. Developmental biology of human hemoglobins. Prog Hematol 1977;10:43-90.
102. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995;92:9647-9651.
103. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta-1 integrins. Nature 1996;380:171-175.
104. + progenitors to peripheral blood. J Exp Med 1997;185:111-120.
105. Li CL, Johnson GR. Murine hematopoietic stem and progenitor cells. I. Enrichment and biologic characterization. Blood 1995;85:1472-1479.
106. + hematopoietic stem cells. Blood 1994;83:3758-3779.
107. Nibley W, Spangrude G. Patterns of myleoid engraftment by progenitor cell subsets in mouse spleen, bone marrow, and blood. Blood 1996;88:456(Abstract).
108. + Lin peripheral blood stem cells (PBSC) transplantation after high dose therapy for patients with multiple myeloma. Blood 1996;88:595 (Abstract).
109. Gazitt Y, et al. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1996;87:805-811.
110. Murphy WJ, Kumar V, Cope JC, Bennett M. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol 1990;144:3305-3311.
111. von Melcher H, Bartlett PF. Mechanisms of early allogeneic graft rejection. Immunol Rev 1983;71:31-56.
112. Gorer PA, Lyman S, Snell GD. Studies on the genetic and antigenic basis of tumour transplantation. Linkage between a histocompatibility gene and "fused" in mice. Proc R Soc Lond G 1948;135:499-505.
113. Gotze D, ed. The major histocompatibility system in man and animals. Berlin: Springer-Verlag; 1977.
114. Cudkowicz G, Stimpfling JH. Deficient growth of C57BL marrow cells transplanted into F1 hybrids. Association with the histocompatibility-2 locus. Immunology 1964;7:291-306.
115. Bennett M. Biology and genetics of hybrid resistance. Adv Immunol 1987;41:333-445.
116. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
117. Rembecki RM, Bennett M, Kumar V, Potter TA. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with transgene regulation. J Immunol 1987;138:2734-2738.
118. Bennett M. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells. J Immunol 1973;110:510-516.
119. Haller O, Wigzell H. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol 1977;118:1503-1506.
120. Murphy WJ, Kumar V, Bennett M. Rejection of hone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987;165:1212-1217.
121. Harrison DE, Carlson GA. Effects of the beige mutation and irradiation on natural resistance to marrow grafts. J Immunol 1983;130:484-489.
122. Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature 1979;278:451-453.
123. Tiberghien P, Longo DL, Wine JW, Alvord WG, Reynolds CW. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 1990;76:1419-1430.
124. Lotzova E, Savary CA, Pollack SB. Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 1983;35:490-494.
125. Shizuru JA, Jerabek L, Edwards CT, Weissman IL. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol Blood Bone Marrow Transplant 1996;2: 3-14.
126. Murphy WJ, Reynolds CW, Tiberghien P, Long DL. Natural killer cells and bone marrow transplantation. J Natl Cancer Inst 1993;85:1475-1478.
127. Dennert G, Anderson CG, Warner J. T killer cells play a role in allogeneic bone marrow graft rejection but not hybrid resistance. J Immunol 1985;135:3729-3734.
128. Yankelevich B, Knobloch C, Nowicki M, Dennert G. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 1989;142:3423-3430.
129. Takeda K, Moore MW, Dennert G. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process. J Immunol 1994;152:4407-4416.
130. Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell depleted marrow for the promotion of engraftment. J Immunol 1991;147:1492-1503.
131. Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic long-term multilineage-repopulation hematopoietic stem cells. Transplantantion 1996;61:125-132.
132. Martin PJ. The role of donor lymphoid cells in allogeneic marrow. Bone Marrow Transplant 1990;6:283-289.
133. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 1971;134:83-102.
134. +cells in the resistance of transplants of bone marrow or other tissues. In: Herberman RB, ed. NK cells and other natural effector cells. New York: Academic Press; 1982. p.1527-1533.
135. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T. In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature 1981;291:334-335.
136. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975;16:230-239.
137. Kiessling R, Petranyi G, Klein G, Wigzell H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer 1975;15:933-940.
138. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
139. Yokoyama WM. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci USA 1995;92:3081-3085.
140. Bezouska K, et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994;372:150-157.
141. Kung SK, Miller RG. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro. J Immunol 1995;154:1624-1633.
142. Scharenberg A, Kinet J. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 1996;87:961-964.
143. + IL-2-activated natural killer cells. Nature 1992;358:66-70.
144. Sentman CL, Hackett J Jr, Kumar V, Bennett M. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med 1989;170:191-202.
145. + cell specificity for Hh-1 determinant 2 shared by H-2d and H-Zf. Eur J Immunol 1991;21:2821-2828.
146. Yu YY, George T, Dorfman JR, Roland J, Kumar V, Bennett M. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 1996;4:67-76.
147. + NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Int Immunol 1996;12:1833-1839.
148. Aguila HL, Weissman IL. Hematopoietic stem cells are not direct targets of natural killer cells. Blood 1996;87:1225-1231.
149. Aguila HL, Hershberger RJ, Weissman IL. Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells. Proc Natl Acad Sci USA 1995;92: 10192-10196.
150. Baker MB, Podack ER, Levy RB. Perforin and fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol Blood Bone Marrow Transplant 1995;1: 69-75.
151. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996;87:1232-1237.
152. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995;165:538-546.
153. Zhang Y, et al. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-defidem mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995;86:2930-2937.
154. Tartaglia LA, Rothe M, Hu YF, Goeddel DV. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213-216.
155. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 1996;157:1919-1925.
156. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2-B10). J Immunol 1986;136:28-33.
157. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 1988;141:2282-2288.
158. Sykes M, Chester CH, Sundt TM, Romick ML, Hoyles KA, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. J Immunol 1989;143:3503-3511.
159. Vallera DA, Soderling CC, Carlson GJ, Kersey JH. Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone. Transplantation 1981;31:218-222.
160. Martin PJ, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985;66:664-672.
161. Vallera DA, Blazar BR. T cell depletion for graft-versus-host-disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 1989;47:751-760.
162. Lapidot T, Lubin I, Terenzi A, Faktorowich Y, Erlich P, Reisner Y. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc Natl Acad Sci USA 1990;87:4595-4599.
163. Martin PJ. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 1993;178:703-712.
164. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 1995;60:355-361.
165. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994;84:2436-2446.
166. Ikehara S. The prospects for BMT-from mouse to human. In: Ikehara FT, Good RA, eds. Bone marrow transplantation. Tokyo: Springer-Verlag; 1996. p.302-331.
167. van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-187.
168. Ikehara S, et al. Rationale for bone marrow transplantation in the treatment of autoimmune disease. Proc Natl Acad Sci USA 1985;82:2483-2487.
169. Ikehara S, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-3310.
170. Möller G, ed. Models of autoimmunity. Immunol Rev 1993;118.
171. Todd JA, Bell JI, McDevitt HO. HLA DQβ gene contributes to susceptibility and resistance to insulin dependent diabetes. Nature 1987;329:599-604.
172. Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Baillieres Clin Endocrinol Metab 1995;9: 631-656.
173. Reich E, Sherwin R, Kanagawa O, Janeway Jr C. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989;341:326-328.
174. Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1989;328:432-434.
175. Knaan-Shanzer S, Houben P, Kinwel-Bohre E, van Bekkum D. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-338.
176. van Bekkum D, Bohre E, Holben F, Knaan-Shanzer S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989;86: 10090-10094.
177. van Gelder M, van Bekkum D. Effective treatment of relapsing experimental autoimmune encephalomyelitis in rats with pseudoautologous bone marrow-transplantation. Bone Marrow Transplant 1996;18: 1029-1034.
178. van Gelder M, Kinwel-Bohre EP, van Bekkum DW Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993;11:233-241.
179. Euler H, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-3625.
180. Marmont AM, Van Bekkum DW. Stern cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant 1995;16:497-498.
181. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13:179-200.
182. Acha-Orbea H, McDevitt H. The first external domain of the nonobese diabetic mouse class II I-Ab chain is unique. Proc Natl Acad Sci USA 1987;84:2435-2439.
183. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 1988;240:659-662.
184. Ikehara S, et al. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;81:7743-7747.
185. MacDonald HR, Blanc C, Lees RK, Sordat B. Abnormal distribution of T cell subsets in athymic mice. J Immunol 1986;136:4337-4339.
186. Hunig T, Bevan MJ. Specificity of cytotoxic T cells from athymic mice. J Exp Med 1980;152:688-702.
187. Kruisbeek AM, Sharrow SO, Singer A. Differences in the MHC-restricted self-recognition repertoire of intra-thymic and extra-thymic cytotoxic T lymphocyte precursors. J Immunol 1983;130:1027-1032.
188. Poussier P, Edouard P, Lee C, Binnie M, Julius M. Thymus-independent development and negative selection of T cells expressing T cell receptor alpha/beta in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J Exp Med 1992;176:187-199.
189. Benveniste P, Miller RG. Differentiation from precursors in normal bone marrow of spontaneously cytotoxic cells showing anti-self-MHC specificity. J Immunol 1986;136:4399-4406.
190. Dejbakhsh-Jones S, Okazaki H, Strober S. Similar rates of production of T and B lymphocytes in the bone marrow. J Exp Med 1995;181:2201-2211.
191. - alpha beta bone marrow T cells with suppressor activity. J Immunol 1992;148:373-380.
192. Cheng L, Dejbakhsh-Jones S, Liblau R, Zeng D, Strober S. Different patterns of TCR transgene expression in single-positive and double-negative T cells. J Immunol 1996;156:3591-3601.
193. Dejbakhsh-Jones S, Jerabek L, Weissman IL, Strober S. Extrathymic maturation of alpha beta T cells from hemopoietic stem cells. J Immunol 1995;155:3338-3344.
194. Antica M, Wu L, Shortman K, Scollay R. Thymic stem cells in mouse bone marrow. Blood 1994;84:111-117.
195. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995;3:459-473.
196. Wu L, Scollay R, Egerton M, Pearse M, Spangrude GJ, Shortman K. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 1991;349:71-74.
197. Wu L, Antica M, Johnson GR, Scollay R, Shortman K. Developmental potential of the earliest precursor cells from the adult mouse thymus. J Exp Med 1991;174:1617-1627.
198. Matsuzaki Y, et al. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med 1993;178:1283-1292.
199. Weissman IL. Developmental switches in the immune system. Cell 1994;76:207-218.
200. Adkins B, Mueller C, Okada CY, Reichert RA, Weissman IL, Spangrude GJ. Early events in T-cell maturation. Annu Rev Immunol 1987;5:325-365.
201. Zuniga-Pflucker JC, Di J, Lenardo MJ. Requirement for TNF-alpha and IL-1-alpha in fetal thymocyte commitment and differentiation. Science 1995;268:1906-1909.
202. Groettrup M, et al. A novel disulfide-linked heterodimer on pre-T cells consists of the T cell receptor beta chain and a 33 kd glycoprotein. Cell 1993;75:283-294.
203. Saint-Ruf C, Ungewiss K, Groettrup M, Bruno L, Fehling HJ, von Boehmer H. Analysis and expression of a cloned pre-T cell receptor gene. Science 1994;266:1208-1212.
204. Fehling HJ, Krotkova A, Samt-Ruf C, von Boehmer H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 1995;375:795-798.
205. Rodewald HR, Kretzschmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995;3:313-319.
206. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 1992;149:2281-2285.
207. Sudo T, et al. Expression and function of the imerleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA 1993;90:9125-9129.
208. + maturation pathway in mouse thymic T cell development: lineages and selection. Immunity 1996;5:147-161.
209. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
210. Peschon JJ, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
211. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965.
212. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992;258:1955-1957.
213. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 1993;151:2546-2554.
214. Gratiot-Deans J, Merino R, Nunez G, Turka LA. Bcl-2 expression during T cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc Natl Acad Sci USA 1994;91: 10685-10689.
215. Gratiot-Deans J, Ding L, Turka LA, Nunez G. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation. J Immunol 1993;151:83-91.
216. Moore NC, Anderson G, Williams GT, Owen JJ, Jenkinson EJ. Developmental regulation of bcl-2 expression in the thymus. Immunology 1994;81:115-119.
217. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1994;1:197-205.
218. Guidos CJ, Weissman IL, Adkins B. Developmental potential of CD4-negative-8-negative thymocytes: peripheral progeny include mature CD4-negative-8-negative T cells bearing alpha beta T cell receptor. J Immunol 1989;142:3773-3780.
219. - intermediate. J Exp Med 1993;178:265-277.
220. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-103.
221. Huesmann M, Scott B, Kisielow P, von Boehmer H. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 1991;66:533-540.
222. +) thymocytes as post-selection intermediates leading to mature T cells. J Exp Med 1991;173:323-332.
223. Weissman IL. Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes. J Exp Med 1973;137:504-510.
224. Weissman IL, Levy R. In vitro cortisone sensitivity of in vivo cortisone-resistant thymocytes. Isr J Med Sci 1975;11:884-888.
225. von Boehmer H. Positive selection of lymphocytes. Cell 1994;76:219-228.
226. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
227. Marrack P, et al. The effect of thymus environment on T cell development and tolerance. Cell 1988;53:627-634.
228. Nossal GJ. Negative selection of lymphocytes. Cell 1994;76:229-239.
229. + thymocytes: selection rather than instruction? Science 1993;261:911-915.
230. van Meerwijk JP, O'Connell EM, Germain RN. Evidence for lineage commitment and initiation of positive selection by thymocytes with intermediate surface phenotypes. J Immunol 1995;154:6314-6323.
231. Grusby MJ, et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Nad Acad Sci USA 1993;90:3913-3917.
232. Crump AL, Grusby MJ, Glimcher LH, Cantor H. Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages. Proc Natl Acad Sci USA 1993;90: 10739-10743.
233. Chan SH, Cosgrove D, Waltzinger C, Benoist C, Mathis D. Another view of the selective model of thymocyte selection. Cell 1993;73:225-136.
234. Tao B, Fultz PN. Molecular and biological analyses of quasispecies during evolution of a virulent simian immunodeficiency virus, SIVsmmPBj14. J Virol 1995;69:2031-2037.
235. Akashi K, Weissman IL. The c-kit-positive maturation pathway in mouse thymic T cell development: lineages and selection. Immunity 1996;5:147-161.
236. Guidos CJ, Danska JS, Fathman CG, Weissman IL. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med 1990;172:835-846.
237. Alam SM, Crispe IN, Gascoigne NR. Allelic exclusion of mouse T cell receptor alpha chains occurs at the time of thymocyte TCR up-regulation. Immunity 1995;3:449-458.
238. Petrie HT, Livak F, Schatz DG, Strasser A, Crispe IN, Shortman K. Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes. J Exp Med 1993;178:615-622.
239. Borgulya P, Kishi H, Uematsu Y, von Boehmer H. Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell 1992;69:529-537.
240. int thymocytes with up-regulated levels of TCR-CD3. J Immunol 1995;155:3806-3814.
241. Lundberg K, Shortman K. Small cortical thymocytes are subject to positive selection. J Exp Med 1994;179:1475-1483.
242. + T cell lineages: a new perspective on thymic commitment and selection. Immunity 1995;2:413-425.
243. + thymocyte differentiation. Immunity 1996;5:461-477.
244. Nakayama K, et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993;261:1584-1588.
245. Levin R, Levine S. Development of circadian periodicity in base and stress levels of corticosterone. Am J Physiol 1975;229:1397-1399.
246. Sentman CL, Shutter JR, Hockenberry D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991;67:879-888.
247. Lagasse E, Weissman I. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 1994;179:1047-1052.
248. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986;44:817-829.
249. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992;356:494-499.
250. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 1986;47:19-28.
251. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;128:1440-1443.
252. Vaux DL, Cory S, Adams J. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
253. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-899.
254. McDonnell TJ, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
255. Willoughby DA, Giroud JP. The role of polymorphonuclear leucocytes in acute inflammation in agranulocytic rats. J Pathol 1969;98:53-60.
256. Lancaster MG, Allison FJ. Studies on the pathogenesis of acute inflammation. VII. The influence of osmolality upon the phagocytic and clumping activity by human leukocytes. Am J Pathol 1966;49:1185-1200.
257. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982;156:430-442.
258. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
259. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991;338:720-722.
260. Jones ST, Denton J, Holt PJ, Freemont AJ. Possible clearance of effete polymorphonuclear leucocytes from synovial fluid by cytophagocytic mononuclear cells: implications for pathogenesis and chronicity in inflammatory arthritis. Ann Rheum Dis 1993;52:121-126.
261. Haslett C, Lee A, Savill JS, Meagher L, Whyte MK. Apoptosis (programmed cell death) and functional changes in aging neutrophils. Modulation by inflammatory mediators. Chest 1991;99:6.
262. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-875.
263. Hockenbery DM. The bcl-2 oncogene and apoptosis. Semin Immunol 1992;4:413-420.
264. Delia D, et al. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992;79:1291-1298.
265. Savill J, Fadok Y Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-136.
266. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993;74:823-832.
267. Breuer M, Slebos R, Verbeek S, van Lohuizen M, Wientjens E, Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 1989;340:61-63.
268. Morello D, Moore G, Salmon AM, Yaniv M, Babinet C. Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice. Eur Mol Biol Organisation J 1986;5: 1877-1883.
269. Spangrude GJ, Scollay R. Differentiation of hematopoietic cells in irradiated mouse thymic lobes. J Immunol 1990;145:3661-3668.
270. Bauman JG, de Vries P, Pronk B, Visser JW. Purification of murine hematopoietic stem cells and committed progenitors by fluorescense activated cell sorting using wheat germ agglutin and monoclonal antibodies. Acta Histochem 1988;36:241-253.
271. Griffiths SD, et al. Interleukin 7-dependent lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 1994;179:1789-1797.
272. Grillot DAM, Merino R, Nunez G. Bcl-Xl displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 1995;182:1973-1983.
273. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ. Bcl-xl and Bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821-828.
274. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
275. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106-112.
276. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
277. Gallacin M, St. John TP, Siegelman M, Reichert R, Butcher EC, Weissman IL. Lymphocyte homing receptors. Cell 1986;44:673-680.
278. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983;304:30-34.
279. Berlin C, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185-195.
280. Holzmann B, McIntyre BW, Weissman IL. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell 1989;56:37-46.
281. - cells to colonize lymph nodes. Proc Natl Acad Sci USA 1996;93: 11019-11024.
282. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996;184:1999-2006.